← Leaderboards
Jeffrey R. Marks
Duke University
$14,495,323
Attributed
$16,108,052
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.2M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,358,049 · 7
By mechanism
U01$8,908,777 · 2
U2C$5,796,389 · 1
P50$1,608,441 · 2
R01$1,044,442 · 2
Top collaborators
- Cha-Mei Tang6 shared
- Lars J Grimm1 shared
Most similar at Duke University
Same institution · by research overlap
- Marc Ryser$1,717,774
- Mary H Foster$6,787,316
- Lars J Grimm$1,055,430
- William P Segars$11,455,061
- Terrie Edith Moffitt$16,369,386
Others in their field
Top investigators on “Early Diagnosis”
- Michael W Weiner · Northern California Institute Res &Educ$162,576,753
- Mitchell D Schnall · University Of Pennsylvania$148,421,012
- David Heimbrook · Leidos Biomedical Research, Inc.$98,656,722
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$85,695,840
- Sharon A Nachman · Johns Hopkins University$77,262,665
- Peter J O'Dwyer · University Of Pennsylvania$75,791,391
Research focus
Early DiagnosisBaseGene ExpressionBreast Cancer DetectionMalignant Breast NeoplasmBreastSeriesProspectiveMalignant NeoplasmsPredictive ValueDiagnosisCollaborationsValidationBiological MarkersModalitySamplingClinical ResearchBreast Cancer DiagnosisRecommendationDetectionLaboratoriesBiomarkerLeadDiagnostic
Grant awards (29)
Dynamic imaging and tissue biomarker models to delineate indolent from aggressive breast calcifications$802,303
R01 · FY2025 · CA
Breast Cancer Detection Consortium$179,116
U01 · FY2021 · CA · contact PI
Breast Cancer Detection Consortium$438,654
U01 · FY2020 · CA · contact PI
Breast Cancer Detection Consortium$423,712
U01 · FY2019 · CA · contact PI
Molecular, Cellular and Tissue Characterization Unit$5,796,389
U2C · FY2018 · CA · contact PI
Breast Cancer Detection Consortium$447,894
U01 · FY2018 · CA · contact PI
Breast Cancer Detection Consortium$454,587
U01 · FY2017 · CA · contact PI
Breast Cancer Detection Consortium$479,193
U01 · FY2016 · CA · contact PI
Atlantic Breast and Gynecologic Clinical Validation Center$18,078
U01 · FY2015 · CA · contact PI
Atlantic Breast and Gynecologic Clinical Validation Center$483,318
U01 · FY2014 · CA · contact PI
Atlantic Breast and Gynecologic Clinical Validation Center$468,371
U01 · FY2013 · CA · contact PI
Atlantic Breast and Gynecologic Clinical Validation Center$479,070
U01 · FY2012 · CA · contact PI
Atlantic Breast and Gynecologic Clinical Validation Center$498,270
U01 · FY2011 · CA · contact PI
Atlantic Breast and Gynecologic Clinical Validation Center$513,677
U01 · FY2010 · CA · contact PI
Expression Based Markers for Breast Cancer Detection$298,999
U01 · FY2009 · CA · contact PI
Expression Based Markers for Breast Cancer Detection$407,728
U01 · FY2008 · CA · contact PI
Expression Based Markers for Breast Cancer Detection$359,918
U01 · FY2007 · CA · contact PI
Expression Based Markers for Breast Cancer Detection$399,493
U01 · FY2006 · CA · contact PI
Expression Based Markers for Breast Cancer Detection$551,192
U01 · FY2005 · CA
Expression Based Markers for Breast Cancer Detection$385,623
U01 · FY2004 · CA
EXPRESSION BASED MARKERS FOR BREAST CANCER DETECTION$384,445
U01 · FY2003 · CA
EXPRESSION BASED MARKERS FOR BREAST CANCER DETECTION$423,957
U01 · FY2002 · CA
SPORE IN BREAST CANCER$249,997
P50 · FY2002 · CA
ROLE OF THE BRCA1 GENE IN SPORADIC CANCER$179,222
P50 · FY2002 · CA
EXPRESSION BASED MARKERS FOR BREAST CANCER DETECTION$412,367
U01 · FY2001 · CA
SPORE IN BREAST CANCER$1,000,000
P50 · FY2000 · CA
EXPRESSION BASED MARKERS FOR BREAST CANCER DETECTION$401,115
U01 · FY2000 · CA
BRCA2$242,139
R01 · FY2000 · CA
ROLE OF THE BRCA1 GENE IN SPORADIC CANCER$179,222
P50 · FY2000 · CA